Treatment of stroke using domain V of perlecan
Date
2013-06-18
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
United States. Patent and Trademark Office
Abstract
The present invention is drawn to methods of stimulating or enhancing angiogenesis in a patient comprising, administering to said patient a therapeutically effective amount of an endorepellin protein, wherein said endorepellin protein has an amino acid sequence of domain V of perlecan or fragments or derivatives, analogs thereof; and stimulating or enhancing generation of blood vessels. The present invention is drawn to compositions for enhancing angiogenesis.